| iShares Global Aggregate Bond ESG (AUD Hedged) ETF (AESG) |
Financials |
$355 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:31AM |
$97.720 |
$97.010 |
fallen by
0.73%
|
|
| iShares Core MSCI World Ex Australia ESG Leaders ETF (IWLD) |
Financials |
$1,697 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:31AM |
$63.110 |
$70.150 |
risen by
11.16%
|
|
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
$3,213 |
Update on status of discussions with CC Capital Partners
|
1 Jul 2025 8:30AM |
$3.630 |
$4.790 |
risen by
31.96%
|
|
| Proteomics International Laboratories Ltd (PIQ) ORDINARY FULLY PAID |
Health Care |
$19 |
Funding boost for precision diagnostics Proteomics Facility
|
1 Jul 2025 8:30AM |
$0.325 |
$0.113 |
fallen by
65.38%
|
|
PIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Proteomics International Laboratories Ltd received a $1.48 million funding boost from the Western Australian Government to support the establishment of a Precision Diagnostics Proteomics Facility.
- The funding will help establish a globally unique facility for the development and production of precision diagnostics, accelerating commercialisation of diagnostic tests including PromarkerD for diabetic kidney disease.
- The new facility will be housed in the Harry Perkins Institute of Medical Research at the QEII Medical Centre in Perth.
- The initiative aims to address the urgent need for precision diagnostics, especially for chronic diseases like diabetes and cancer, by enabling local production and reducing reliance on overseas suppliers.
- The facility will create new jobs and attract skilled talent in Western Australia while strengthening the region’s biotechnology and medical research sector.
- Proteomics International’s PromarkerD test is the world’s first predictive diagnostic test for diabetic kidney disease and is internationally recognised.
- The funding and facility are expected to support further diagnostic test development as well as industry partnerships and collaboration with universities and hospitals.
- The State Government sees this as a step towards transforming WA into a hub for advanced medical technology and commercialisation.
- The announcement highlights the alignment between government, academic, and industry interests in expanding the life sciences and health technology sectors.
- Proteomics International’s leadership expressed gratitude for the government’s support and emphasised the facility’s global significance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paragon Care Limited (PGC) ORDINARY FULLY PAID |
Health Care |
$232 |
Change of Director's Interest Notice
|
1 Jul 2025 8:30AM |
$0.365 |
$0.140 |
fallen by
61.64%
|
|
| Paragon Care Limited (PGC) ORDINARY FULLY PAID |
Health Care |
$232 |
Notification regarding unquoted securities - PGC
|
1 Jul 2025 8:29AM |
$0.365 |
$0.140 |
fallen by
61.64%
|
|
| Mineral Resources Limited (MIN) ORDINARY FULLY PAID |
Materials |
$12,888 |
Appendix 3Y and 3Z - James McClements
|
1 Jul 2025 8:29AM |
$21.560 |
$65.210 |
risen by
202.46%
|
|
| Euro Manganese Inc (EMN) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$14 |
Notification of cessation of securities - EMN
|
1 Jul 2025 8:29AM |
$0.190 |
$0.095 |
fallen by
50%
|
|
| Fortescue Ltd (FMG) ORDINARY FULLY PAID |
Materials |
$59,886 |
Appendix 3X - Yasmin Broughton
|
1 Jul 2025 8:29AM |
$15.280 |
$19.450 |
risen by
27.29%
|
|
| Sprintex Limited (SIX) ORDINARY FULLY PAID |
Consumer Discretionary |
$46 |
Extension of Note and Loan Agreements
|
1 Jul 2025 8:29AM |
$0.044 |
$0.066 |
risen by
50%
|
|
SIX - Price-sensitive ASX Announcement
Full Release
Key Points
- Sprintex Limited extended the maturity dates of its Unsecured Convertible Note Deed and Unsecured Loan Agreement with SIX to 30 June 2024.
- The previous maturity date for both agreements was 30 June 2023.
- Interest on the convertible notes and the loan will continue at 10% per annum, payable quarterly in arrears.
- The extension provides Sprintex additional time and flexibility for financial management and strategic planning.
- Key terms such as conversion rights, repayment, and interest payments remain unchanged except for the new maturity date.
- Sprintex will keep shareholders updated on future developments regarding these agreements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sprintex Limited (SIX) ORDINARY FULLY PAID |
Consumer Discretionary |
$46 |
Notification of cessation of securities - SIX
|
1 Jul 2025 8:29AM |
$0.044 |
$0.066 |
risen by
50%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,555 |
Appendix 3C
|
1 Jul 2025 8:29AM |
$51.900 |
$39.870 |
fallen by
23.18%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,555 |
Appendix 3C
|
1 Jul 2025 8:29AM |
$51.900 |
$39.870 |
fallen by
23.18%
|
|
| Fortescue Ltd (FMG) ORDINARY FULLY PAID |
Materials |
$59,886 |
Appointment of Non-Executive Director
|
1 Jul 2025 8:29AM |
$15.280 |
$19.450 |
risen by
27.29%
|
|
| SGH Limited (SGH) ORDINARY FULLY PAID |
Industrials |
$18,069 |
Boral CEO Succession
|
1 Jul 2025 8:29AM |
$54.070 |
$44.395 |
fallen by
17.89%
|
|
| Ama Group Limited (AMA) ORDINARY FULLY PAID |
Industrials |
$226 |
Notification of cessation of securities - AMA
|
1 Jul 2025 8:29AM |
$0.105 |
$0.470 |
risen by
347.62%
|
|
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$53 |
NMR Expects to Pour First Gold at Blackjack Next Week
|
1 Jul 2025 8:28AM |
$0.185 |
$0.048 |
fallen by
74.05%
|
|
| Besra Gold Inc (BEZ) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$35 |
Statement of CDIs on issue - BEZ
|
1 Jul 2025 8:28AM |
$0.054 |
$0.083 |
risen by
53.70%
|
|
| Shine Justice Ltd (SHJ) ORDINARY FULLY PAID |
Consumer Discretionary |
$102 |
Notification of cessation of securities - SHJ
|
1 Jul 2025 8:28AM |
$0.700 |
$0.600 |
fallen by
14.29%
|
|
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$58,067 |
Notice of Proposed Sale of Securities
|
1 Jul 2025 8:28AM |
$102.650 |
$104.000 |
risen by
1.32%
|
|
| Stellar Resources Limited (SRZ) ORDINARY FULLY PAID |
Materials |
$109 |
Extended Drill Program at Heemskirk
|
1 Jul 2025 8:28AM |
$0.016 |
$0.032 |
risen by
100%
|
|
SRZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Stellar Resources Limited (SRZ) announced an extended drill program at Heemskirk Tin Project.
- The program targets expansion and upgrading of the Mineral Resource at Queen Hill and Severn deposits.
- Drill targets are based on recent geological interpretations and focus on areas with potential for resource growth.
- Details of planned drill holes and technical rationale for target selection are provided.
- Positive drill results could significantly increase the resource base and enhance project economics.
- The Heemskirk project is positioned as a key asset within the global tin industry.
- The announcement discusses alignment with the company's broader development and feasibility plans.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,005 |
Update - Notification of buy-back - KAR
|
1 Jul 2025 8:28AM |
$1.920 |
$1.415 |
fallen by
26.30%
|
|
| Nido Education Limited (NDO) ORDINARY FULLY PAID |
Consumer Discretionary |
$70 |
Update - Notification of buy-back - NDO
|
1 Jul 2025 8:28AM |
$0.690 |
$0.310 |
fallen by
55.07%
|
|
| Next Science Limited (NXS) ORDINARY FULLY PAID |
Health Care |
- |
Next Science to Sell Majority of Assets
|
1 Jul 2025 8:28AM |
$0.067 |
$0.145 |
risen by
116.42%
|
|
NXS - Price-sensitive ASX Announcement
Full Release
Key Points
- Next Science Limited has agreed to sell the majority of its assets to Biomea Fusion, Inc. for US$90 million.
- The sale excludes certain assets and liabilities, with key product lines and intellectual property included.
- Shareholder and regulatory approvals are required for the transaction to proceed.
- Proceeds will be used to settle liabilities, cover transaction costs, and return surplus funds to shareholders.
- The Board cites competitive pressures, financial constraints, and funding challenges as reasons for the decision.
- An Independent Expert has determined the transaction is fair and reasonable to shareholders.
- The Board unanimously recommends shareholders vote in favor of the asset sale.
- Failure to proceed with the transaction may result in significant financial risk to the company.
- A shareholder meeting is scheduled to seek approval for the sale.
- The transaction is positioned as the best available option for maximizing shareholder value in current circumstances.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Equinox Resources Limited (EQN) ORDINARY FULLY PAID |
Materials |
- |
Company Secretary Appointment/Resignation
|
1 Jul 2025 8:28AM |
$0.076 |
$0.080 |
risen by
5.26%
|
|